•Journal•ISSN: 2473-9529
Blood Advances
American Society of Hematology
About: Blood Advances is an academic journal published by American Society of Hematology. The journal publishes majorly in the area(s): Medicine & Internal medicine. It has an ISSN identifier of 2473-9529. It is also open access. Over the lifetime, 3370 publications have been published receiving 59675 citations.
Topics: Medicine, Internal medicine, Transplantation, Myeloid leukemia, Hematopoietic stem cell transplantation
Papers
More filters
••
TL;DR: There was a lack of evidence to support strong recommendations for various management approaches, and a large focus was placed on shared decision-making, especially with regard to second-line therapy.
569 citations
••
Duke University1, Pontifical Catholic University of Chile2, Veterans Health Administration3, University of Florida4, Kaiser Permanente5, University of Pennsylvania6, University of Amsterdam7, Harvard University8, University of California, Davis9, McMaster University10, I.M. Sechenov First Moscow State Medical University11, Washington University in St. Louis12, Katholieke Universiteit Leuven13, University of Utah14, University of Antioquia15
TL;DR: Recommendations include the use of thrombolytic therapy for patients with PE and hemodynamic compromise, use of an international normalized ratio (INR) range, and a preference for direct oral anticoagulants over VKA for primary treatment of VTE.
497 citations
••
McMaster University1, University of Vermont Medical Center2, University of New Mexico3, McGill University4, King's College London5, Universidade Federal de Minas Gerais6, Beth Israel Deaconess Medical Center7, State University of New York System8, University of Modena and Reggio Emilia9, Pontifical Catholic University of Chile10
TL;DR: These evidence-based guidelines from the American Society of Hematology intend to support patients, clinicians, and others in decisions about preventing VTE in medical inpatients and outpatients with minor injuries and long-distance travelers.
448 citations
••
TL;DR: These evidence-based guidelines of the American Society of Hematology are intended to support patients, clinicians, and other health care professionals in their decisions about diagnosis and management of HIT.
386 citations
••
Fred Hutchinson Cancer Research Center1, University of Washington2, Ottawa Hospital Research Institute3, Medical University of Vienna4, University of Chieti-Pescara5, University of Toronto6, Case Western Reserve University7, University of California, San Francisco8, University of British Columbia9, Provincial Health Services Authority10, McMaster University11, Cardiff University12, University of Minnesota13, American University of Beirut14, Cochrane Collaboration15
TL;DR: In this paper, the authors present evidence-based guidelines of the American Society of Hematology (ASH) to support patients, clinicians, and other health care professionals in their decisions about the prevention and treatment of VTE in patients with cancer.
284 citations